Determination of Etofibrate, Fenofibrate, and Atorvastatin in Pharmaceutical Preparations and Plasma Using Differential Pulse Polarographic and Square Wave Voltammetric TechniquesKORANY, Mohamed A; HEWALA, Ismail I; ABDEL-HAY, Karim M et al.Journal of AOAC International. 2008, Vol 91, Num 5, pp 1051-1058, issn 1060-3271, 8 p.Article

Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe : A Phase I, open-label, multiple-dose, three-period crossover study in healthy subjectsGUSTAVSON, Linda E; SCHWEITZER, Sarah M; BURT, David A et al.Clinical therapeutics. 2006, Vol 28, Num 3, pp 373-387, issn 0149-2918, 15 p.Article

Paradoxical decreases in high-density lipoprotein cholesterol with fenofibrate : a quite common phenomenonMAGEE, G; SHARPE, P. C.Journal of clinical pathology. 2009, Vol 62, Num 3, pp 250-253, issn 0021-9746, 4 p.Article

Thin-layer chromatography-densitometry : Determination of fenofibrate and gemfibrozil in pharmaceuticals by densitometric and videodensitometric thin-layer chromatographyKOMSTA, Łlukasz; MISZTAL, Genowefa.Journal of AOAC International. 2005, Vol 88, Num 5, pp 1517-1524, issn 1060-3271, 8 p.Article

After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study : Implications for FenofibrateSACKS, Frank M.The American journal of cardiology. 2008, Vol 102, Num 12, issn 0002-9149, 34L-40L, SUPArticle

Inhibitory effect of fenofibrate on neointima hyperplasia via G₀/G₁ arrest of cell proliferationLEE, Jung-Jin; YU, Ji-Yeon; ZHANG, Wei-Yun et al.European journal of pharmacology. 2011, Vol 650, Num 1, pp 342-349, issn 0014-2999, 8 p.Article

Paradoxical Decrease in High-Density Lipoprotein Cholesterol with Fenofibrate: A Ouite Rare Phenomenon IndeedMOMBELLI, Giuliana; PAZZUCCONI, Franco; BONDIOLI, Alighiero et al.Cardiovascular therapeutics (Print). 2010, Vol 28, Num 3, pp 153-160, issn 1755-5914, 8 p.Article

Fabrication of a uniformly sized fenofibrate microemulsion by membrane emulsificationPRADHAN, Roshan; DONG WON LEE; CHOI, Han-Gon et al.Journal of microencapsulation. 2013, Vol 30, Num 1, pp 42-48, issn 0265-2048, 7 p.Article

Gynecomastia associated with fenofibrateGARDETTE, Virginie; VEZZOSI, Delphine; MAIZA, Jean-Christophe et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 3, pp 508-511, issn 1060-0280, 4 p.Article

Simultaneously measuring concentrations of a model drug and a model excipient in solution using ultrasonic spectrometryCHEN, Raymond R; ZELESKY, Todd; ILASI, Nicholas et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 2, pp 239-247, issn 0731-7085, 9 p.Article

Analysis of PPARα-dependent and PPARα-independent transcript regulation following fenofibrate treatment of human endothelial cellsARAKI, Hiromitsu; TAMADA, Yoshinori; TOMIYASU, Yuki et al.Angiogenesis (London). 2009, Vol 12, Num 3, pp 221-229, issn 0969-6970, 9 p.Article

Rhabdomyolyse induite par le fénofibrate en monothérapie = Rhabdomyolysis induced by fenofibrate monotherapyARCHAMBEAUD-MOUVEROUX, F; LOPEZ, S; COMBES, C et al.La Revue de médecine interne (Paris). 2006, Vol 27, Num 7, pp 573-574, issn 0248-8663, 2 p.Article

Pharmacokinetics and comparative bioavailability of two fenofibrate capsule formulations in healthy volunteersVLASE, Laurian; POPA, Adina; MUNTEAN, Dana et al.Arzneimittel-Forschung. 2010, Vol 60, Num 9, pp 560-563, issn 0004-4172, 4 p.Article

Determination of fenofibric acid concentrations by HPLC after anion exchange solid-phase extraction from human serumSTRAKA, Robert J. D; BURKHARDT, R. Todd; FISHER, James E et al.Therapeutic drug monitoring. 2007, Vol 29, Num 2, pp 197-202, issn 0163-4356, 6 p.Article

A new fenofibrate formulation: Results of six single-dose, clinical studies of bioavailability under fed and fasting conditionsGUIVARC'H, Pol-Henri; VACHON, Michael G; FORDYCE, Diana et al.Clinical therapeutics. 2004, Vol 26, Num 9, pp 1456-1469, issn 0149-2918, 14 p.Article

Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statinJONES, Peter H; DAVIDSON, Michael H.The American journal of cardiology. 2005, Vol 95, Num 1, pp 120-122, issn 0002-9149, 3 p.Article

Effectiveness and tolerability of Simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)GRUNDY, Scott M; VEGA, Gloria L; ZHONG YUAN et al.The American journal of cardiology. 2005, Vol 95, Num 4, pp 462-468, issn 0002-9149, 7 p.Article

Fenofibrate-induced photosensitivityLEENUTAPHONG, V; MANUSKIATTI, W.Journal of the American Academy of Dermatology. 1996, Vol 35, Num 5, pp 775-777, issn 0190-9622, 1Article

Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemiaKOWALSKI, J; OKOPIEN, B; MADEJ, A et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 6, pp 241-247, issn 0946-1965, 7 p.Article

More Clinical Lessons from the FIELD StudyFAZIO, Sergio.Cardiovascular drugs and therapy. 2009, Vol 23, Num 3, pp 235-241, issn 0920-3206, 7 p.Article

Fenofibric acid, an active form of fenofibrate, increases apolipoprotein A-I-mediated high-density lipoprotein biogenesis by enhancing transcription of ATP-binding cassette transporter A1 gene in a liver X receptor-dependent mannerARAKAWA, Reijiro; TAMEHIRO, Norimasa; NISHIMAKI-MOGAMI, Tomoko et al.Arteriosclerosis, thrombosis, and vascular biology. 2005, Vol 25, Num 6, pp 1193-1197, issn 1079-5642, 5 p.Article

Proceedings/Fenofibrate, a third-generation fibric acid derivative, symposium, Dallas TX, November 15, 1986BROWN, W. V.The American journal of medicine. 1987, Vol 83, Num 5, issn 0002-9343, 89 p., BConference Proceedings

A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet NetworkASLIBEKYAN, Stella; KABAGAMBE, Edmond K; ORDOVAS, Jose M et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 3, pp 191-197, issn 1744-6872, 7 p.Article

Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silicaVAN SPEYBROECK, Michiel; MELLAERTS, Randy; MOLS, Raf et al.European journal of pharmaceutical sciences. 2010, Vol 41, Num 5, pp 623-630, issn 0928-0987, 8 p.Article

Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile saltYAPING CHEN; YI LU; JIANMING CHEN et al.International journal of pharmaceutics (Print). 2009, Vol 376, Num 1-2, pp 153-160, issn 0378-5173, 8 p.Article